Elevated expression of caveolin-1 at protein and mRNA level in human cirrhotic liver: relation with nitric oxide

Hiroaki Yokomori1, Masaya Oda, Kazunori Yoshimura

  • 1Department of Internal Medicine, Kitasato Institute Medical Center Hospital, 121-1 Arai, Kitamoto 364-8501, Japan.

Abstract

Insights

Enhanced caveolin-1 expression in cirrhotic liver may significantly reduce nitric oxide (NO) activity. This study investigated caveolin and eNOS levels in liver disease patients.

Area of Science:

  • Hepatology
  • Molecular Biology
  • Biochemistry

Background:

  • Caveolin binds endothelial nitric oxide synthase (eNOS), inhibiting its activity.
  • Caveolae are cellular structures whose principal protein is caveolin.

Purpose of the Study:

  • To examine caveolin and eNOS expression at protein and mRNA levels.
  • To compare expression in hepatocellular carcinoma and hepatitis C-related cirrhosis patients versus controls.

Main Methods:

  • Western blotting using specific antibodies for eNOS, caveolin-1, and calmodulin.
  • In situ hybridization (ISH) with peptide nucleic acid probes for eNOS and caveolin-1 mRNA.

Main Results:

  • Marked overexpression of caveolin-1 protein and mRNA in cirrhotic liver tissue.
  • eNOS protein and mRNA expression showed minimal changes in cirrhosis.
  • Calmodulin protein levels were reduced in cirrhotic liver.

Conclusions:

  • Increased caveolin-1 expression correlates with reduced NO catalytic activity in cirrhosis.
  • Caveolin-1 may play a role in the pathophysiology of liver cirrhosis.

Related Concept Videos

Nitric Oxide Signaling Pathway01:28

Nitric Oxide Signaling Pathway

Nitric oxide (NO), an inorganic gas, acts as a potent second messenger in most animal and plant tissues. NO diffuses out of the cells that produce it and enters the neighboring cells to generate a downstream response. NO synthase (NOS) catalyzes NO production by the deamination of the amino acid arginine. There are three isoforms of NOS. Endothelial cells have endothelial NOS (eNOS), nerve and muscle cells have neuronal NOS (nNOS), and macrophages produce inducible NOS (iNOS) upon exposure to...
Cirrhosis I: Introduction01:23

Cirrhosis I: Introduction

Cirrhosis is a chronic, irreversible liver disease characterized by the widespread replacement of healthy liver tissue with fibrotic scar tissue and the formation of regenerative nodules.Etiology of cirrhosisCirrhosis results from sustained liver injury that triggers progressive fibrosis and structural remodeling. The underlying causes are diverse, encompassing common and less frequent clinical conditions. Regardless of the origin, all causes lead to chronic inflammation, hepatocyte loss, and...
Cirrhosis II: Pathophysiology01:24

Cirrhosis II: Pathophysiology

Cirrhosis is a progressive chronic liver injury caused by prolonged inflammation, excessive fibrotic remodeling, and impaired regeneration. Over time, repeated hepatic insults disrupt the liver’s architecture and function, leading to reduced blood flow, impaired bile drainage, and diminished metabolic capacity.Pathophysiology of cirrhosisCirrhosis arises from three main responses to chronic liver damage: inflammation, immune activation, and hepatocyte death. These processes lead to structural...
NF-κB-dependent Signaling Pathway02:26

NF-κB-dependent Signaling Pathway

The transcription factor NF-κB was discovered in 1986 in the lab of Nobel laureate Professor David Baltimore, for its interaction with the immunoglobulin light chain enhancer in B-cells. After more than three decades of study, it is now evident that NF-κB regulates the expression of over 100 genes. Most of these genes play an essential role in the innate and adaptive immune responses as well as the inflammatory responses of animals.
NF-κB-dependent Signaling Mechanism
The heterodimer of NF-κB...
Regulation of Angiogenesis and Blood Supply01:24

Regulation of Angiogenesis and Blood Supply

Rapidly dividing tumors, embryos, and wounded tissues require more oxygen than usual, lowering the oxygen concentration in the blood. At low oxygen or hypoxic conditions, an oxygen-sensitive transcription factor called the hypoxia-inducible factor 1 or HIF1 is activated. HIF1 is a dimeric protein of alpha (ɑ) and beta (β) subunits.  Under optimal oxygen conditions, HIF1β is present in the nucleus while HIF1ɑ remains in the cytosol. HIF1ɑ is hydroxylated by prolyl hydroxylase and factor...